AlphaYouHB
Insider selling
Harold Bernstein sold $270K of Maze Therapeutics, Inc. (MAZE) stock
Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc. (MAZE), sold 10,295 shares of MAZE stock worth $270K, per an SEC Form 4 filed Sep 4, 2026.
It was an open-market sale.
The trade happened on Sep 2, 2026, 2 days before it was made public.
MAZE has moved +6.2% since the trade date, from $26.72 to $28.38 (Sep 22, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 4, 2026
- Filing delay
- 2 days
- Price since
- +6.2%
- Role
- President, R&D & CMO
- Source
- SEC Form 4
More MAZE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.